Axcan Pharma Inc.
TSX : AXP
NASDAQ : AXCA

Axcan Pharma Inc.

December 06, 2006 12:00 ET

Axcan Pharma to Host Analyst and Investor Presentation in New York on December 12, 2006

MONT-SAINT-HILAIRE, QUEBEC--(CCNMatthews - Dec. 6, 2006) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Tuesday, December 12, 2006, the Company will host an Analyst and Investor Presentation in New York City, NY at 11:30 a.m. (Eastern time).

Members of the Axcan management team will provide an overview of Axcan's business. The event will also include a discussion on guidance for fiscal 2007.

Due to space limitations, prior registration is necessary for this presentation. Analysts and investors interested in attending should contact Paulina Dolgov from Christensen IR at (480) 614-3017, or by e-mail at pdolgov@ChristensenIR.com.

A live and archived webcast of the event, including presentation slides, will be available at www.axcan.com.

ABOUT AXCAN PHARMA

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

  • Axcan Pharma Inc.
    Isabelle Adjahi
    Director, Investor Relations
    450-467-2600 ext. 2000
    www.axcan.com